Brand:Bettli
Description:Product name:Anastrozole Synonym:Arimidex CAS Registry Number:120511-73-1 Molecular Formula:C17H19N5 Molecular Weight:293.37 Assay:99% Appearance:White to white crystalline powder
Origin:Other country Hong Kong
Model:120511-73-1
MOQ:10GramsGram/Grams
Port:Hong Kong,Shanghai,Shenzhen
Payment Terms:T/T
Supply Time:Day
Delivery Time:2017-09-18
Packaging Details:Suitable package according to your quantity
Product detail:Basic Info
Product name | Anastrozole |
Synonym | ARIMIDEX |
CAS Registry Number | 120511-73-1 |
Molecular Formula | C17H19N5 |
Molecular Weight | 293.37 |
Assay | 99% |
Appearance | White to white crystalline powder |
De
In studies that have been done, Arimidex has been shown to reduce estrogen in the body by roughly 50%. This is a good balance for bodybuilders , because some estrogen is needed in order for the full anabolic benefits of the steroids being taken to be achieved. These results are typically the same with a dosage of .5 mg a day as they are with a dosage of 1 mg a day, meaning that in most cases, a half tablet a day will be sufficient for estrogen control throughout cycle.
Usage:
An aromatase inhibitor. Used as an antineoplastic raw materials.
Potent selective triazole aromatase inhibitors, can inhibit the cytochrome P-450 aromatase enzyme which depends blocking the biosynthesis of estrogen, and estrogen to stimulate breast cancer cell growth factors. Treatment of breast cancer, especially for those with hormone relapse after adjuvant therapy after menopause for women with advanced breast cancer.
Our Advantages:
1.Rich experience. Our company is a professional production leading factory in China for many years, our products have exported to Germany, Spain, UK, USA, Australia, Middle East and so many other countries , and we have got very good feedback from our customers, we had Established long friendly
relations of cooperation.
2.Great quality, purity and favorable price. Good quality is one of our secret success!
3.Safe and fast delivery.
4.Good after-sales service.
Welcome to inquiry!